Relapse of Acute Myeloid Leukemia with t(16;21)(p11;q22) Mimicking Autoimmune Pancreatitis after Second Allogeneic Bone Marrow Transplantation
Author(s) -
Yuhei Kamada,
Kazumi Suzukawa,
Kenichi Taoka,
Yasushi Okoshi,
Yuichi Hasegawa,
Shigeru Chiba
Publication year - 2011
Publication title -
isrn hematology
Language(s) - English
Resource type - Journals
eISSN - 2090-4428
pISSN - 2090-441X
DOI - 10.5402/2011/285487
Subject(s) - medicine , myeloid leukemia , pancreatitis , autoimmune pancreatitis , transplantation , bone marrow , leukemia , myeloid , pancreas transplantation , pathology , kidney transplantation
We report the case of a 37-year-old woman who had a relapse of acute myeloid leukemia (AML) during treatment for chronic graft versus host disease (cGVHD) after allogeneic bone marrow transplantation. She was originally suspected of having autoimmune pancreatitis. Relapse of AML often occurs at extramedullary sites. Whereas the pancreas is rare as an organ of AML relapse, physicians should be aware that enlargement of the pancreas could be a sign of relapsed AML when excluding autoimmune pancreatitis, particularly during active cGVHD after allogeneic stem cell transplantation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom